Skip to main
TWST

TWST Stock Forecast & Price Target

TWST Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 27%
Buy 45%
Hold 18%
Sell 0%
Strong Sell 9%

Bulls say

Twist Bioscience is positioned to capitalize on the rapidly growing synthetic biology market with its disruptive DNA synthesis platform, strong customer base, and expanding geographic reach. The company has demonstrated strong financials, with a significant portion of its revenues coming from the lucrative NGS segment. Additionally, the company's focus on cost efficiency and operational scale provides a clear path to higher gross margins and profitability, making it an attractive investment for long-term growth potential.

Bears say

Twist Bioscience is experiencing significant momentum in their NGS segment, and the company's growing focus on artificial intelligence (AI) is expected to drive continued revenue growth over the coming quarters. However, there are two key risks to this positive outlook: potential competition in the NGS market and any slowdown in NGS momentum. Additionally, while the company's AI-driven orders are currently driving growth, there is potential for this to be a sustained demand driver in the future.

TWST has been analyzed by 11 analysts, with a consensus rating of Buy. 27% of analysts recommend a Strong Buy, 45% recommend Buy, 18% suggest Holding, 0% advise Selling, and 9% predict a Strong Sell.

This aggregate rating is based on analysts' research of Twist Bioscience Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Twist Bioscience Corp (TWST) Forecast

Analysts have given TWST a Buy based on their latest research and market trends.

According to 11 analysts, TWST has a Buy consensus rating as of Sep 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $103, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $103, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Twist Bioscience Corp (TWST)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.